The EMJ Podcast | Episode 131
In this week’s episode, Jonathan Sackier is joined by Annalisa Jenkins, a biopharma thought leader with over 25 years of experience in the industry. The pair discuss Jenkins’ time in the Royal Navy, her role as non-executive director of Genomics England, and how connecting human and financial capital can help create an environment conducive to success.
Spotify | Apple | Amazon Music | Download MP3 (mp3, 32:47 mins)
Speaker bio:
Annalisa Jenkins completed her medical education at Saint Bartholomew’s Medical School, London, followed by a fellowship at the Royal College of Physicians, London, UK. She was a medical officer in the British Royal Navy. She has served in a variety of senior roles at Bristol Myers Squibb, as well as Merck Serono. She is a board member of several growing companies, including Oncimmune, AVROBIO, COMPASS Pathways, AOBiome, AgeX; a medical trustee for the British Heart Foundation; a committee member of the Science Board to the U.S. Food and Drug Administration (FDA); advisory board member at FasterCures; and Chair of Court at the London School of Hygiene and Tropical Medicine.
